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PROGNOSTIC SIGNIFICANCE AND DIAGNOSTIC VALUE OF PTEN AND p53 
                   EXPRESSION IN ENDOMETRIAL CARCINOMA 
Abstract 
Introduction  
Endometrial cancer has become the most common invasive gynecological 
neoplasm in the developed countries. The incidence is lower in developing countries due 
to less use of hormone replacement therapy. It occurs more commonly in postmenopausal 
women who present with vaginal bleeding as their chief complaint. The neoplasm is 
categorized into two histological types, the endometriod and the non endometriod types. 
They vary in terms of their source of origin and prognosis. Besides surgery, many 
targeted therapies have been introduced for treatment rendering better prognosis. 
Aims and Objectives: 
To study the clinicopathological profile of endometrial cancers, including age, 
clinical presentation, menopausal status, stage of presentation and to categorize them into 
different types based on histological type and grade. 
To observe the immunohistochemical expression of PTEN and p53 in endometrial 
carcinomas and to compare the expression with clinical stage and other histopathological 
parameters. 
 
Methods and materials 
36 hysterectomy cases of endometrial carcinomas reported during the period from 
2013 to 2016 in the department of Pathology of our institution were considered in this 
study. Immunohistochemistry staining for PTEN and p53 were performed and the results 
were determined. 
Results 
The mean age of the patients was 55.5 years. 30 out of 36 patients were post 
menopausal and presented with postmenopausal bleeding.  All the patients in our study 
were type 1 endometrial carcinoma.19 patients had grade I tumours and 16 patients had 
grade 2 tumours. As per FIGO staging, 28 patients were stage IA, 4 patients were stage 
IB and 4 patients were stage 2. 19 patients had histological grade 1 tumours and 16 
patients had histological grade 2 tumours. PTEN status was predominantly negative 
(n=25) or heterogeneous (n=9) in these tumours. PTEN status was positive in only 2 
patients with grade 2 tumours. p53 immunostaining revealed that  majority of patients 
had low p53 score. p53 staining showed similar distribution in stage IA and  IB  tumours.  
Conclusion  
The inactivation of PTEN in higher grades and stages of endometrial carcinomas 
helps to understand the theranostics of endometrial carcinomas and predicting the 
response to targeted therapies against carcinogenic pathways.  
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